m-Trifluoromethyl-diphenyl diselenide (m-CF
Adaptation, Physiological
Animals
Antidepressive Agents
/ pharmacology
Behavior, Animal
Depression
/ drug therapy
Hippocampus
/ drug effects
Mice
Morphine
Narcotics
Neuroprotective Agents
/ pharmacology
Neurotoxicity Syndromes
/ physiopathology
Organosilicon Compounds
/ pharmacology
Oxidative Stress
/ drug effects
Phenotype
Signal Transduction
/ drug effects
Substance Withdrawal Syndrome
/ drug therapy
Depressive-like
Neuroprotection
Opioid withdrawal syndrome
Organoselenium
Oxidative stress
Journal
Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617
Informations de publication
Date de publication:
02 03 2020
02 03 2020
Historique:
received:
11
07
2019
revised:
17
10
2019
accepted:
31
10
2019
pubmed:
7
11
2019
medline:
23
11
2021
entrez:
6
11
2019
Statut:
ppublish
Résumé
The opioid withdrawal syndrome is defined as a complex phenomenon involving multiple cellular adaptations, which leads to the emergence of aversive physical and affective signs. The m-trifluoromethyl-diphenyl diselenide (m-CF
Identifiants
pubmed: 31689445
pii: S0278-5846(19)30576-7
doi: 10.1016/j.pnpbp.2019.109803
pii:
doi:
Substances chimiques
Antidepressive Agents
0
Narcotics
0
Neuroprotective Agents
0
Organosilicon Compounds
0
m-trifluoromethyl-diphenyl diselenide
0
Morphine
76I7G6D29C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109803Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.